Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome
- 10 December 2019
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 26 (8) , 4431-4447
Abstract
Methamphetamine (Meth) abuse has reached epidemic proportions in many countries and can induce psychotic episodes mimicking the clinical profile of schizophrenia. Brain-derived neurotrophic factor (BDNF) is implicated in both Meth effects and schizophrenia. We therefore studied the long-term effects of chronic Meth exposure in transgenic mice engineered to harbor the human BDNFVal66Met polymorphism expressed via endogenous mouse promoters. These mice were chronically treated with an escalating Meth regime during late adolescence. At least 4 weeks later, all hBDNFVal66Met Meth-treated mice exhibited sensitization confirming persistent behavioral effects of Meth. We used high-resolution quantitative mass spectrometry-based proteomics to biochemically map the long-term effects of Meth within the brain, resulting in the unbiased detection of 4808 proteins across the mesocorticolimbic circuitry. Meth differentially altered dopamine signaling markers (e.g., Dat, Comt, and Th) between hBDNFVal/Val and hBDNFMet/Met mice, implicating involvement of BDNF in Meth-induced reprogramming of the mesolimbic proteome. Targeted analysis of 336 schizophrenia-risk genes, as well as 82 growth factor cascade markers, similarly revealed that hBDNFVal66Met genotype gated the recruitment of these factors by Meth in a region-specific manner. Cumulatively, these data represent the first comprehensive analysis of the long-term effects of chronic Meth exposure within the mesocorticolimbic circuitry. In addition, these data reveal that long-term Meth-induced brain changes are strongly dependent upon BDNF genetic variation, illustrating how drug-induced psychosis may be modulated at the molecular level by a single genetic locus.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (1041895, 1057741, 1139489)
- La Trobe University Research Focus Area grant
This publication has 77 references indexed in Scilit:
- Gender, Brain-Derived Neurotrophic Factor Val66Met, and Frequency of Methamphetamine UseGender Medicine, 2012
- Methamphetamine-Associated PsychosisJournal of Neuroimmune Pharmacology, 2011
- Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsBioinformatics, 2010
- BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal functionProceedings of the National Academy of Sciences, 2010
- Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology AspectsSchizophrenia Bulletin, 2009
- Repeated Exposure to Methamphetamine Causes Long-Lasting Presynaptic Corticostriatal Depression that Is Renormalized with Drug ReadministrationNeuron, 2008
- AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia FamiliesBiological Psychiatry, 2008
- Genetic Modulation of BDNF Signaling Affects the Outcome of Axonal Competition In VivoCurrent Biology, 2007
- Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related BehaviorScience, 2006
- Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophreniaNature Neuroscience, 2002